Dipak Patil

6PUBLICATIONS
3CO-AUTHORS
Immunogenetics (incl. genetic immunology)Pharmaceutical delivery technologiesPharmacogenomicsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
Semaglutide Injection Once-Weekly for Weight Management in Adults: Results From A Randomized Phase III, Active-Controlled Study.

|May 31, 2026
Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III, Active-Controlled Study.

|May 12, 2026
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority Study.

|May 03, 2026
Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical Study.

|Apr 14, 2026
Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active-Controlled Study.

Brij Mohan, S Vasanth Kumar, Prakash Harishchandra Kurmi

|Aug 19, 2025
Efficacy and Safety of Triple Fixed Dose Combination of Dapagliflozin + Sitagliptin + Metformin IR in Indian Patients with Type 2 Diabetes Mellitus: A Randomized, Phase 3 Study in Comparison with Dual FDC Sitagliptin + Metformin IR.

Mahendra Pal Singh, Sandeep Gupta, Manish Singh

Pageof 1

Frequent Collaborators

2 joint publications

Shweta Bhandari

1 joint publications

Dipesh Sonawane

1 joint publications

Supriya Sonowal